Propofol Use in the Elderly Population: Prevalence of Overdose and Association With 30-Day Mortality
| Autor: | Adam T. Phillips, Hung-Mo Lin, Evie Andreopoulos, Stacie Deiner, Matthew A. Levin, Jeffrey H. Silverstein |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Male
Mean arterial pressure Drug-Related Side Effects and Adverse Reactions Population Article Interquartile range Prevalence Humans Medicine Pharmacology (medical) education Adverse effect Propofol Aged Retrospective Studies Aged 80 and over Pharmacology education.field_of_study business.industry Mortality rate Retrospective cohort study Blood pressure Anesthesia Female business Anesthetics Intravenous medicine.drug |
| Zdroj: | Clinical Therapeutics. 37:2676-2685 |
| ISSN: | 0149-2918 |
| DOI: | 10.1016/j.clinthera.2015.10.005 |
| Popis: | Purpose Geriatric patients are more sensitive to the anesthetic effects of propofol and its adverse effects, such as hypotension, than is the general population; thus, a reduced dose (1–1.5 mg/kg) is recommended for the induction of anesthesia. The extent to which clinicians follow established dosing guidelines has not been well described. Therefore, we investigated the prevalence of propofol overdose in the elderly population to determine whether propofol overdose occurs and is associated with increased hypotension and 30-day mortality. Methods In this retrospective study in patients who received propofol for the induction of general anesthesia, data on demographic characteristics, preoperative medications, intraoperative management, and 30-day mortality were collected. The dose of propofol used for the induction of anesthesia and the median blood pressure in the pre- and immediate postinduction periods were determined. Hypotension was defined as either: (1) a decrease in mean arterial pressure (MAP) of >40% concurrent with a MAP of Findings A total of 17,540 patients were included in the analysis; 4033 (23.0%) were aged >65 years. The median (interquartile range) propofol dose in the group aged >65 years was 1.8 (1.4–2.2) mg/kg, above the recommended dose, in comparison to 2.2 (1.9–2.5) mg/kg in younger patients. On multivariate analysis, increased propofol dose was associated with increased postinduction hypotension, especially in patients over 70 years of age, but not 30-day mortality. Implications Older patients received greater-than-recommended doses of propofol for induction, which may have led to significant dose-dependent hypotension. Despite this finding, the dose of propofol for induction was not independently associated with a greater 30-day mortality rate. More education regarding geriatric concerns is needed for encouraging anesthesiologists to tailor the plan for anesthesia in geriatric patients. However, overall postsurgical mortality is a function of preoperative risk and type surgical procedure. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect